SCHEMBL3864724

SCHEMBL3864724

Cc1c(N=C2C=CC(=O)C=C2)c(=O)n(-c2ccccc2)n1C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 11/20 1.00
▸ MAPT P10636 10/20 1.00
▸ GAA P10253 8/20 1.00
▸ MEN1 O00255 4/20 1.00
▸ KMT2A Q03164 4/20 1.00
▸ KDM4E B2RXH2 3/20 1.00
▸ MPI P34949 3/20 1.00
▸ THRB P10828 2/20 1.00
▸ BLM P54132 1/20 1.00
▸ MAPK1 P28482 5/20 0.72
▸ ATM Q13315 1/20 0.72
▸ HTT P42858 3/20 0.69
▸ LMNA P02545 3/20 0.69
▸ POLB P06746 3/20 0.66
▸ TDP1 Q9NUW8 2/20 0.66
▸ G6PD P11413 1/20 0.66
▸ RECQL P46063 1/20 0.66
▸ TP53 P04637 1/20 0.63
▸ HSP90AA1 P07900 1/20 0.63
▸ HSP90AB1 P08238 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13680120 0.87 MAPT (0.76) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL3854531 0.84 MAPT (1.00) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL22585319 0.84 MAPT (0.72) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL13680051 0.84 MAPT (1.00) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL3854527 0.84 MAPT (1.00) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL13680121 0.83 ALDH1A1 (0.71) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL3858944 0.82 MAPT (0.70) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL13679925 0.82 MAPT (0.70) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL3858947 0.82 MAPT (0.70) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL20122064 0.82 MAPT (0.78) ALDH1A1MAPTGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230220442-A1 Random Heteropolymers Preserve Protein Function in Foreign Environments THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-07-13 — — US disclosed
US-20230220442-A1 Random Heteropolymers Preserve Protein Function in Foreign Environments THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-07-13 — — US disclosed
US-11597845-B2 Coating for aldehyde remediation and method of making DOW GLOBAL TECHNOLOGIES LLC (US) 2023-03-07 — — US disclosed
US-20210275997-A9 MAGNETIC MACROPOROUS POLYMERIC HYBRID SCAFFOLDS FOR IMMOBILIZING BIONANOCATALYSTS ZYMTRONIX CATALYTIC SYSTEMS, INC. (US) 2021-09-09 — — US disclosed
US-20200330967-A1 MAGNETIC MACROPOROUS POLYMERIC HYBRID SCAFFOLDS FOR IMMOBILIZING BIONANOCATALYSTS ZYMTRONIX CATALYTIC SYSTEMS, INC. (US) 2020-10-22 — — US disclosed
US-20200318154-A1 Random Heteropolymers Preserve Protein Function in Foreign Environments THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-10-08 — — US disclosed
US-20200165463-A1 COATING FOR ALDEHYDE REMEDIATION AND METHOD OF MAKING GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2020-05-28 — — US disclosed
US-7582123-B2 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-09-01 — — US disclosed
US-7582123-B2 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-09-01 — — US disclosed
US-7582123-B2 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-09-01 — — US disclosed
US-20090044348-A1 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-02-19 — — US disclosed
US-20090044348-A1 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-02-19 — — US disclosed
US-20090044348-A1 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-02-19 — — US disclosed
EP-2011787-A1 Dying composition comprising an azomethin-type compound with a pyrazolinone moiety L'Oreal (FR) 2009-01-07 — — EP disclosed
US-20070196861-A1 METHOD FOR FORMING FILM, BASE PLATE WITH FILM, SENSOR, AND LIQUID COMPOSITION SEIKO EPSON CORPORATION (JP) 2007-08-23 — — US disclosed
US-20070196861-A1 METHOD FOR FORMING FILM, BASE PLATE WITH FILM, SENSOR, AND LIQUID COMPOSITION SEIKO EPSON CORPORATION (JP) 2007-08-23 — — US disclosed
US-6989254-B2 Direct encapsulation of biomacromolecules in surfactant templated mesoporous and nanoporous materials DREXEL UNIVERSITY (US) 2006-01-24 — — US disclosed
US-20040014189-A1 Direct encapsulation of biomacromolecules in surfactant templated mesoporous and nanoporous materials DREXEL UNIVERSITY 2004-01-22 — — US disclosed
WO-2002010218-A1 DIRECT ENCAPSULATION OF BIOMACROMOLECULES IN SURFACTANT TEMPLATED MESOPOROUS AND NANOPOROUS MATERIALS DREXEL UNIVERSITY (US) 2002-02-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090044348-A1 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit KRT18, KMO, TMPO ALDH1A1 729/4885MAPT 308/4885GAA 4421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback